Opto Circuits receives USFDA approval to market New Powerheart G5 AED with CPRD

06 May 2015 Evaluate

Opto Circuits (India)’s group company - Cardiac Science Corporation’s Powerheart G5 AED with CRPD has received 510(k) market clearance from the US FDA (Food and Drug Administration), allowing the company to begin selling the AED with CPRD along with its successful Powerheart G3 and G5 product line. The Powerheart family of AEDs is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered sudden cardiac arrest (SCA).

Cardiac Science has been working to reduce SCA fatalities since it introduced the first fully automated external defibrillator. The Powerheart G5 with CPRD will be available for purchase in the United States later this year.

Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.



Opto Circuits (I) Share Price

1.78 0.00 (0.00%)
23-May-2022 18:01 View Price Chart
Peers
Company Name CMP
Poly Medicure 2581.85
Hemant Surgical Inds 136.50
Nureca Ltd. 273.50
Prevest Denpro 540.00
Centenial Surgical 125.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.